Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (4): 404-408.DOI: 10.3969/j.issn.1673-8640.2025.04.016
Previous Articles Next Articles
Received:
2024-05-11
Revised:
2024-10-10
Online:
2025-04-30
Published:
2025-05-08
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.04.016
[1] | DULLENS B, DE PUTTER R, LAMBERTINI M, et al. Cancer surveillance in healthy carriers of germline pathogenic variants in BRCA1/2:a review of secondary prevention guidelines[J]. J Oncol, 2020, 2020:9873954. |
[2] | 钟泽澄, 王进, 张师音. 多重PCR技术研究进展[J]. 生物工程学报, 2020, 36(2):171-179. |
[3] |
中国抗癌协会肿瘤标志物专业委员会,上海市抗癌协会肿瘤标志物专业委员会. 基于中国人群的BRCA胚系突变筛查专家共识(2024年版)[J]. 中国癌症杂志, 2024, 34(2):220-238.
DOI |
[4] |
CHAMBERLAIN J S, GIBBS R A, RANIER J E, et al. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification[J]. Nucleic Acids Res, 1988, 16(23):11141-11156.
DOI PMID |
[5] | HINDIYEH M, HILLYARD D R, CARROLL K C. Evaluation of the ProdesseHexaplex multiplex PCR assay for direct detection of seven respiratory viruses in clinical specimens[J]. Am J Clin Pathol, 2001, 116(2):218-224. |
[6] | WALLACE, ANDREW J. New challenges for BRCA testing:a view from the diagnostic laboratory[J]. Eur J Hum Genet, 2016, 24(Suppl 1):S10-S18. |
[7] | STROM C M, RIVERA S, ELZINGA C, et al. Development and validation of a next-generation sequencing assay for BRCA1 and BRCA2 variants for the clinical laboratory[J]. PLoS One, 2015, 10(8):e0136419. |
[1] | ZHENG Yong, LÜ Lei, HE Kai. Clinical roles of serum GDF15 and YKL-40 in elderly patients with gallbladder cancer [J]. Laboratory Medicine, 2025, 40(4): 377-382. |
[2] | GUI Jing, WANG Feng, CAI Yumao, HONG Chuangyue, YANG Hui. Correlation between oxidized high-density lipoprotein and comorbidity of T2DM and PTB [J]. Laboratory Medicine, 2025, 40(4): 350-357. |
[3] | CHEN Weilong, WANG Yongbing, CHEN Zegang. Correlation between ZBED3,CYFRA21-1,VEGF and short-term mortality risk in patients with advanced liver cancer [J]. Laboratory Medicine, 2025, 40(4): 338-343. |
[4] | GUO Tingting, LOU Huan, HU Hangzhan, YANG Xiaofeng. Analysis of genetic causes and related factors of spontaneous abortion in the first trimester of pregnancy [J]. Laboratory Medicine, 2025, 40(4): 383-387. |
[5] | MA Xiaolu, GUO Lin, LU Renquan. Clinical value and application prospect of circulating biomarkers in hepatocellular carcinoma patients [J]. Laboratory Medicine, 2025, 40(4): 309-316. |
[6] | TIAN Ze, LIU Hongrui, SI Wenzhe. Research progress of exosomal miRNA as biomarkers of hepatocellular carcinoma [J]. Laboratory Medicine, 2025, 40(4): 317-323. |
[7] | SUN Haiqing, LIU Ning, LOU Jinli, YU Yanhua. Clinical role of STIP1 and AFP-L3 combined determination in diagnosing HCC [J]. Laboratory Medicine, 2025, 40(4): 324-330. |
[8] | . [J]. Laboratory Medicine, 2025, 40(4): 400-403. |
[9] | DAI Jingwen, YANG Shuo, WANG Chong, SUN Lin, GU Meixiu, XIAN Jingrong, PAN Baishen, WANG Beili, ZHANG Chunyan, GUO Wei. Role of preoperative mean corpuscular hemoglobin concentration for predicting postoperative recurrence in intrahepatic cholangiocarcinoma patients [J]. Laboratory Medicine, 2025, 40(4): 344-349. |
[10] | LI Hu, ZHU Weinan, CHEN Feng, WANG Jiawei, LIU Ying, SHEN Lisong, ZHENG Yingxia. Molecular characteristics and virulence analysis of hypermucoviscous carbapenem-resistant Klebsiella pneumonia [J]. Laboratory Medicine, 2025, 40(4): 358-364. |
[11] | ZHANG Guoying, LU Zhongkui, WANG Yuling, XIA Xia, MENG Ke, HE Fang, HUANG Zihui, YANG Zengmin, LIU Xin. Application of gamma-interferon inducible protein-10 mRNA determination technology in diagnosis of extrapulmonary tuberculosis [J]. Laboratory Medicine, 2025, 40(4): 372-376. |
[12] | ZHENG Ying, LU Zhe, XUE Jing. Relationship between serum 25(OH)D3 level and lymphocyte subsets in children with systemic lupus erythematosus [J]. Laboratory Medicine, 2025, 40(3): 230-234. |
[13] | SHU Ming. Roles of serum VCAM-1,Gal-3 and Hcy expression levels in evaluating patients with coronary heart disease [J]. Laboratory Medicine, 2025, 40(3): 247-252. |
[14] | YU Jiajie, ZHANG Zhizhi, LUO Qingqiong, KE Xing. Predicting early colorectal tumor risk using a deep learning model based on multiple serum tumor markers [J]. Laboratory Medicine, 2025, 40(3): 253-258. |
[15] | WANG Xiaolong, CHEN Yuanbin. Relationship between serum cell division cyclin 42 and clinicopathological characteristics and prognosis of AFP-negative hepatocellular carcinoma patients [J]. Laboratory Medicine, 2025, 40(3): 259-263. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||